Venture Capital


Osler has a leading venture capital team dedicated to helping investors and emerging companies recognize, develop and realize upon significant and innovative venture capital opportunities. We have worked on more than 150 VC deals over the past three years, representing more than $1.6 billion of investment in Canadian private companies.

We advise clients in the information technology, life sciences, biotechnology, cleantech and alternative energy sectors and have worked with numerous SR&ED-based financings and collaborative research arrangements that access these and related funding sources. Our team advises both investors and Canadian companies accessing private capital on the unique issues involved in venture capital deals. In addition to working with Canadian funds, we also advise many U.S. funds on their Canadian investments and in M&A transactions for portfolio companies.

Cross-Border Expertise / Mergers and Acquisitions

Osler has pioneered some of Canada’s most innovative structures to accommodate the unique regulatory and tax constraints that affect cross-border investments. We have the know-how and experience to help U.S. and other foreign investors take equity positions in Canadian companies in ways that satisfy their tax objectives (both on the way into a Canadian venture and also with an eye to any potential exit transaction) and that also preserve relevant tax attributes of the Canadian business. Whether as counsel to a Canadian business or to the lead investors in that business, we have played a significant role in many of the notable M&A transactions involving venture-backed Canadian companies.

Fund Formation

Our venture capital team has worked closely with the managers of leading Canadian-focused funds on their fund formation activities. Our strong deal flow means that we are always on top of market practice, including issues as to fund structure, manager compensation, governance arrangements for the management/GP entity and the amount and structuring of carried interests. We also advise Canadian and U.S. private equity funds on acquisitions and divestitures of portfolio investments, on managing third-party funds and on secondary sale transactions.

Emerging Companies

In addition to our work with established companies, we work closely with emerging companies throughout their growth cycle to provide practical and cost-effective advice on all aspects of their development, including corporate structure, financing, IP, human resources, commercial matters and the preparation for and execution of IPO and M&A transactions.


Related Expertise

Robert Lehodey Q.C.

Partner, Corporate

Ed Vandenberg

Partner, Corporate

Chad Bayne

Partner, Emerging and High Growth Companies

Shahir Guindi Ad. E.

National Co-chair

André Perey

Partner, Emerging and High Growth Companies

Mark Longo

Partner, Emerging and High Growth Companies
  • Fusion Pharmaceuticals

    Fusion Pharmaceuticals in its US$20 million commitment by the Canada Pension Plan Investment Board

  • Security Compass

    Security Compass in its growth equity funding by FTV Capital

  • EcoPackers

    EcoPackers in its $4.3 million seed round

  • Deep Genomics

    Deep Genomics in its US$40 million Series B financing round

  • SkyWatch Space Applications Inc.

    SkyWatch Space Applications Inc. in its $10 million Series A financing round

  • e-ZN Inc.

    e-ZN Inc. in its $3.4 million seed round

  • LQT Therapeutics Inc.

    LQT Therapeutics Inc. in its $1.8 million seed round

  • Verafin

    Verafin in its $515 million venture funding - the largest venture funding deal in Canada’s history

  • FlexPay

    FlexPay in its $6 million late seed round led by Impression Ventures

  • ScribbleLive

    ScribbleLive in its acquisition by Rock Content

  • Coconut Software

    Coconut Software in its $6.5 million Series A-2 financing round

  • Yaletown Venture Partners & BDC Capital

    Yaletown Venture Partners and BDC Capital in Charli AI's $1.6 million Seed Financing

  • Drive Capital

    Drive Capital in KOHO Financial’s $25 million Series C financing round

  • iGan Partners

    iGan Partners in RNA Diagnostics’ $5 million Series A financing round

  • Winterlight Labs

    Winterlight Labs in its $5.6 million Series A financing

  • Information Venture Partners

    Information Venture Partners in Verafin's $515 million venture funding

  • SV Health Investors

    SV Health Investors in EBT Medical's US$10 million Series A financing round

  • Acton Capital

    Acton Capital in Knix Wear's $5.7 million financing round

  • Accel

    Accel in 1Password's US$200 million Series A financing round

  • Untether AI & Radical Ventures

    Untether AI in its $20 million Series A financing with Radical Ventures

  • Stradigi AI

    Stradigi AI in its $53 million Series A funding

  • Fitplan

    Fitplan in its $4.5 million financing led by ARod, Corazon Capital and Mark Mastrov

  • The Logic

    The Logic in its $1.8 million Seed financing

  • iNovia

    iNovia in RenoRun’s $22.5 million Series A financing

  • Kensington Venture Fund

    Kensington Venture Fund in Pela’s $5 million Series A financing 

  • Find More


  • Refinitiv: #1 Canadian law firm in the Global Venture Capital League Tables